ArticleFrontiers in pharmacology2022
Therapeutic potential of the Proprotein Convertase Subtilisin/Kexin family in vascular disease.
Bianca E Suur et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it